TDOC:NYE-Teladoc Health, Inc (USD)

COMMON STOCK | Other | NYE

Last Closing Price

USD 164.16

Change

+4.66 (+2.92)%

Market Cap

USD 10.34B

Volume

3.86M

Average Target Price

USD 115.95 (-29.36%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, expert medical services, behavioral health solutions, guidance and support, and platform and program services. The company's platform enables patients and providers to have an integrated smart user experience through mobile, Web, and phone based accessed points. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. It offers its products and services under the Teladoc, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-03-27 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BMS Bemis Company, Inc

N/A

USD370,676,430.93B 1,000,000.00 N/A
NAO Nordic American Offshore Ltd

N/A

USD387,070.41B N/A N/A
ITC ITC Holdings Corp

N/A

USD3,166.52B 22.84 N/A
USB-PA U.S. Bancorp PERP PFD SER A

+6.00 (+0.82%)

USD1,222.27B 207.41 N/A
MSF Morgan Stanley Emerging Market..

N/A

USD1,000.65B 24.60 N/A
HSBC-PA HSBC Holdings plc ADR A 1/40PF..

+0.09 (+0.36%)

USD507.19B 52.52 N/A
BRK-A Berkshire Hathaway Inc

-7,969.00 (-2.89%)

USD436.15B 5.36 3.24
SAN-PB Banco Santander, S.A. GTD PFD ..

-0.45 (-2.10%)

USD330.07B 47.16 N/A
JPM-PD JPMorgan Chase & Co

-0.44 (-1.74%)

USD317.53B 2.23 N/A
BAC-PW Bank of America Corporation

N/A

USD267.69B 9.46 N/A

ETFs Containing TDOC

Symbol Name Weight Mer Price(Change) Market Cap
PTH Invesco DWA Healthcare Mo.. 6.96 % 0.60 %

-1.38 (-1.61%)

USD0.17B
ARKG ARK Genomic Revolution ET.. 4.11 % 0.75 %

-1.27 (-3.88%)

USD0.55B
BTEC Principal Healthcare Inno.. 2.41 % 0.42 %

-0.66 (-2.07%)

USD0.06B
HTEC Robo Global Healthcare Te.. 2.33 % 0.68 %

-0.73 (-3.13%)

USD8.93M
PLAT WisdomTree Modern Tech Pl.. 1.79 % 0.00 %

-0.53 (-2.22%)

USD2.59M
JKK iShares Morningstar Small.. 1.52 % 0.30 %

-4.84 (-2.88%)

USD0.21B
FNY First Trust Mid Cap Growt.. 1.26 % 0.70 %

-1.14 (-3.02%)

USD0.30B
IWO iShares Russell 2000 Grow.. 0.99 % 0.24 %

-6.14 (-3.80%)

USD8.80B
VTWG Vanguard Russell 2000 Gro.. 0.68 % 0.15 %

-4.36 (-3.72%)

USD0.80B
VRTGX Vanguard Russell 2000 Gro.. 0.68 % 0.08 %

+214.93 (+%)

USD0.80B
FNX First Trust Mid Cap Core .. 0.67 % 0.61 %

-1.90 (-3.80%)

USD0.76B
BTAL AGFiQ U.S. Market Neutral.. 0.64 % 2.11 %

+0.36 (+1.43%)

USD0.07B
MOM AGFiQ U.S. Market Neutral.. 0.59 % 2.62 %

+0.86 (+3.11%)

USD1.30M
JHSC John Hancock Multifactor .. 0.54 % 0.50 %

-0.77 (-3.88%)

USD0.48B
IWM iShares Russell 2000 ETF 0.52 % 0.19 %

-4.25 (-3.64%)

USD39.91B
AGES:LSE iShares Ageing Population.. 0.52 % 0.40 %

-15.15 (-3.96%)

USD0.28B
2B77:XETRA iShares Ageing Population.. 0.52 % 0.40 %

-0.11 (-2.51%)

USD0.26B
AGED:LSE iShares Ageing Population.. 0.52 % 0.40 %

-0.09 (-1.87%)

USD0.28B
R2SC:LSE SPDR Russell 2000 US Smal.. 0.49 % 0.30 %

-1.21 (-4.57%)

USD0.50B
XRSG:LSE Concept Fund Solutions pl.. 0.37 % 0.30 %

+106.00 (+0.83%)

USD0.65B
XRSU:LSE Xtrackers Russell 2000 UC.. 0.37 % 0.30 %

-4.92 (-2.99%)

USD0.65B
XRS2:XETRA Xtrackers Russell 2000 UC.. 0.37 % 0.30 %

-4.84 (-3.24%)

USD0.65B
XRS2:F Xtrackers Russell 2000 UC.. 0.37 % 0.30 %

-7.98 (-5.28%)

USD0.65B
R2US:LSE SPDR Russell 2000 US Smal.. 0.36 % 0.30 %

-1.28 (-3.92%)

USD0.50B
R2US:PA SPDR Russell 2000 US Smal.. 0.36 % 0.30 %

-0.98 (-3.32%)

USD0.50B
XSU:CA iShares U.S. Small Cap In.. 0.36 % 0.36 %

-0.89 (-3.71%)

USD0.22B
ZPRR:XETRA SPDR Russell 2000 US Smal.. 0.36 % 0.30 %

N/A

USD0.49B
ZPRR:F SPDR Russell 2000 US Smal.. 0.36 % 0.30 %

-1.39 (-4.72%)

USD0.50B
SCHA Schwab U.S. Small-Cap ETF 0.36 % 0.04 %

-1.76 (-3.34%)

USD8.14B
VRTIX Vanguard Russell 2000 Ind.. 0.35 % 0.08 %

-7.39 (-4.09%)

USD2.02B
VTWO Vanguard Russell 2000 Ind.. 0.35 % 0.10 %

-3.62 (-3.84%)

USD2.02B
RWM ProShares Short Russell20.. 0.32 % 0.95 %

+1.60 (+3.38%)

USD0.30B
TZA Direxion Daily Small Cap .. 0.32 % 1.07 %

+5.98 (+10.54%)

USD0.39B
TWM ProShares UltraShort Russ.. 0.32 % 0.95 %

+1.33 (+7.03%)

USD0.10B
WOSC:LSE SPDR MSCI World Small Cap.. 0.17 % 0.45 %

-9.38 (-17.37%)

USD0.38B
WLDS:LSE iShares MSCI World Small .. 0.15 % 0.35 %

N/A

USD0.98B
IUSN:XETRA iShares III plc - iShares.. 0.00 % 0.00 %

-0.11 (-3.08%)

N/A
CUS1:LSE iShares VII Public Limite.. 0.00 % 0.00 %

-1,009.00 (-4.90%)

N/A
URTY ProShares UltraPro Russel.. 0.00 % 0.95 %

-2.21 (-10.52%)

USD0.06B
SRTY ProShares UltraPro Short .. 0.00 % 0.95 %

+2.97 (+10.22%)

USD0.10B
UWM ProShares Ultra Russell20.. 0.00 % 0.95 %

-2.62 (-7.65%)

USD0.16B

Market Performance

  Market Performance vs.
Industry/Classification (Other)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 96.08% 98% A+ 99% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 96.08% 98% A+ 99% A+
Trailing 12 Months  
Capital Gain 205.81% 96% A 99% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 205.81% 96% A 99% A+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 54.86% 75% C 98% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 54.86% 75% C 98% A+
Risk Return Profile  
Volatility (Standard Deviation) 54.39% 25% F 6% F
Risk Adjusted Return 100.87% 75% C 83% B
Market Capitalization 10.34B 82% B- 87% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Other)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 10.20 4% F 5% F
Price / Cash Flow Ratio 346.20 1% F 0% N/A
EV/EBITDA -408.11 100% A+ 100% A+
Management Effectiveness  
Return on Equity -9.75% 17% F 15% F
Return on Invested Capital -4.39% 10% F 11% F
Return on Assets -2.95% 8% F 9% F
Debt to Equity Ratio 43.43% 74% C 67% D+
Technical Ratios  
Short Ratio 3.83 29% F 25% F
Short Percent 18.84% 11% F 35% F
Beta 0.95 47% F 51% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector